Topical treatment of pyoderma gangraenosum

Dermatology

Volumn 205, Issue 2-3, 2002, Pages 221-223

  Wenzel, Joerg ^a   Gerdsen, Rainer ^b   Phillipp Dormston, Wolfgang ^b   Bieber, Thomas ^b   Uerlich, Manfred ^b  

^a UNIVERSITY OF BONN   (Germany)

^b NONE

Author keywords

5 Aminosalicylic acid; Corticosteroid; Cyclosporine; Nitrogen mustard; Sodiumcro moglycate; Tacrolimus

Indexed keywords

AZATHIOPRINE; CHLORMETHINE; CLOFAZIMINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLOSPORIN A; DAPSONE; MESALAZINE; NICOTINE GUM; NICOTINETTE; PREDNISOLONE; SANDIMMUM OPTORAL; TACROLIMUS; UNCLASSIFIED DRUG;

CHRONIC DISEASE; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; REVIEW; SIDE EFFECT; SKIN DEFECT; SYSTEMIC CIRCULATION; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE 17-VALERATE; CROMOLYN SODIUM; GLUCOCORTICOIDS; HUMANS; MESALAMINE; PYODERMA GANGRENOSUM;

EID: 0036976521     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065843     Document Type: Review

References (24)

1. Jorizzo JL, Solomon AR, Zanolli MD, Leshin B: Neutrophilic vascular reactions. J Am Acad Dermatol 1988;19:983-1005.
2. Michel S, Hohenleutner U, Mohr V, Landthaler M: Therapy-resistant pyoderma gangrenosum - Treatment with mycophenolate mofetil and cyclosporine A. Hautarzt 1999;50:428-431.
3. Chow RK, Ho VC: Treatment of pyoderma gangrenosum. J Am Acad Dermatol 1996;34: 1047-1060.
4. Newell LM, Malkinson FD: Commentary: Pyoderma gangrenosum. Arch Dermatol 1982; 118:743-773.
5. Peachey RD: Proceedings: Pyoderma gangrenosum of scalp. Br J Dermatol 1974;90:106-108.
6. Ko CB, Walton S, Wyatt EH: Pyoderma gangrenosum: Associations revisited. Int J Dermatol 1992;31:574-577.
7. Lip P: Sodium cromoglycate (Intal) in the management of chronic leg ulcers. Med J Aust 1978;2:32.
8. de Cock KM, Thorne MG: The treatment of pyoderma gangrenosum with sodium cromoglycate. Br J Dermatol 1980;102:231-233.
9. Tamir A, Landau M, Brenner S: Topical treatment with 1% sodium cromoglycate in pyoderma gangrenosum. Dermatology 1996;192:252-254.
10. Sanders CJ, Hulsmans RF: Successful treatment of pyoderma gangrenosum with topical 5-aminosalicylic acid. Cutis 1993;51:262-264.
11. Tsele E, Yu RC, Chu AC: Pyoderma gangrenosum - Response to topical nitrogen mustard. Clin Exp Dermatol 1992;17:437-440.
12. Faulds D, Goa KL, Benfield P: Cyclosporin: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs 1993;45:953-1040.
13. Duffill MB: Cyclosporine, azathioprine and local therapy for pyoderma gangrenosum. Australas J Dermatol 1994;35:15-18.
14. Mrowietz U, Christophers E: Clearing of pyoderma gangrenosum by intralesional cyclosporin A. Br J Dermatol 1991;125:499.
15. Theissen U, Luger TA, Schwarz T: Successful topical administration of cyclosporin A in pyoderma gangraenosum. Hautarzt 1996;47:132-135.
16. Saitoh O, Matsuse R, Sugi K, Nakagawa K, Uchida K, Maemura K, Kojima K, Hirata I, Katsu K: Cyclosporine A inhibits interleukin-8 production in a human colon epithelial cell line (HT-29). J Gastroenterol 1997;32:605-610.
17. Oka M, Berking C, Nesbit M, Satyamoorthy K, Schaider H, Murphy G, Ichihashi M, Sauter E, Herlyn M: Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts. Lab Invest 2000;80:595-604.
18. Kanekura T, Kanzaki T: Successful treatment of pyoderma gangrenosum with nicotine chewing gum. J Dermatol 1995;22:704-705.
19. Lyon CC, Kirby B, Griffiths CE: Recalcitrant pyoderma gangrenosum treated with systemic tacrolimus. Br J Dermatol 1999;140:562-564.
20. Cooley HM, Castelino D, McNair P, Russell DM, Chohan V, Kay TW: Resolution of pyoderma gangrenosum using tacrolimus (FK-506). Aust NZ J Med 1996;26:238-239.
21. Abu-Elmagd K, Jegasothy BV, Ackerman CD, Thomson AW, Rilo H, Nikolaidis N, Van Thiel D, Fung JJ, Todo S, Starzl TE: Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. Transplant Proc 1991;23:3328-3329.
22. Richter-Hintz D, Schuppe HC, Homey B, Lehmann P, Ruzicka T: Topical tacrolimus (FK 506) is effective in the treatment of pyoderma gangrenosum. J Am Acad Dermatol 2000;42:304-305.
23. Schuppe HC, Homey B, Assmann T, Martens R, Ruzicka T: Topical tacrolimus for pyoderma gangrenosum. Lancet 1998;351:832.
24. Reich K, Vente C, Neumann C: Topical tacrolimus for pyoderma gangrenosum. Br J Dermatol 1998;139:755-757.